Single-cell sequencing data showed that CREM is highly expressed in the CD4+ CTLA4 and CD8+ LAYN population in non-small cell lung cancer (Supplementary Figure S1C), and CREM is highly expressed in the CD8+ T-cell exhaustion population in glioma (Supplementary Figure S1B). The gene discussed is CD4; the disease is central nervous system cancer.